1 |
Addressing national investment incentives for local production of essential antibiotics |
01/07/2021 |
Kenya; Uganda |
|
2 |
Addressing investment incentives for production and supply of essential antibiotics at regional level (East African Community) |
01/07/2021 |
Burundi; Kenya; Rwanda; Tanzania; Uganda |
|
3 |
Pandemic preparedness beyond COVID-19: Investing in vaccines production and supply for LMICs |
21/10/2021 |
Albania; Antigua and Barbuda; Argentina; Armenia; Bahrain, Kingdom of; Barbados; Belize; Bolivia, Plurinational State of; Botswana; Brazil; Brunei Darussalam; Cabo Verde; Cameroon; Chile; China; Colombia; Congo; Costa Rica; Côte d'Ivoire; Cuba; Dominica; Dominican Republic; Ecuador; Egypt; El Salvador; Eswatini; Fiji; Gabon; Georgia; Ghana; Grenada; Guatemala; Guyana; Honduras; Hong Kong, China; India; Indonesia; Israel; Jamaica; Jordan; Kazakhstan; Kenya; Korea, Republic of; Kuwait, the State of; Kyrgyz Republic; Macao, China; Malaysia; Maldives; Mauritius; Mexico; Moldova, Republic of; Mongolia; Montenegro; Morocco; Namibia; Nicaragua; Nigeria; North Macedonia; Oman; Pakistan; Panama; Papua New Guinea; Paraguay; Peru; Philippines; Qatar; Russian Federation; Saint Kitts and Nevis; Saint Lucia; Saint Vincent and the Grenadines; Samoa; Saudi Arabia, Kingdom of; Seychelles; Singapore; South Africa; Sri Lanka; Suriname; Chinese Taipei; Tajikistan; Thailand; Tonga; Trinidad and Tobago; Tunisia; Türkiye; Ukraine; United Arab Emirates; Uruguay; Vanuatu; Venezuela, Bolivarian Republic of; Viet Nam; Zimbabwe |
|
4 |
Advisory services on technology transfer and intellectual property enablement for vaccines manufacturing |
01/07/2021 |
Angola; Benin; Botswana; Burkina Faso; Burundi; Cabo Verde; Cameroon; Central African Republic; Chad; Congo; Côte d'Ivoire; Democratic Republic of the Congo; Djibouti; Egypt; Eswatini; Gabon; The Gambia; Ghana; Guinea; Guinea-Bissau; Kenya; Lesotho; Liberia; Madagascar; Malawi; Mali; Mauritania; Mauritius; Morocco; Mozambique; Namibia; Niger; Nigeria; Rwanda; Senegal; Seychelles; Sierra Leone; South Africa; Tanzania; Togo; Tunisia; Uganda; Zambia; Zimbabwe |
|
5 |
Technical advice on regional cooperation for pharmaceutical sector development |
10/11/2021 |
Burundi; Kenya; Rwanda; Tanzania; Uganda |
|
6 |
Capacity building and advisory services on regional cooperation on intellectual property rights |
01/07/2020 |
Angola; Benin; Botswana; Burkina Faso; Burundi; Cabo Verde; Cameroon; Central African Republic; Chad; Congo; Côte d'Ivoire; Democratic Republic of the Congo; Djibouti; Egypt; Eswatini; Gabon; The Gambia; Ghana; Guinea; Guinea-Bissau; Kenya; Lesotho; Liberia; Madagascar; Malawi; Mali; Mauritania; Mauritius; Morocco; Mozambique; Namibia; Niger; Nigeria; Rwanda; Senegal; Seychelles; Sierra Leone; South Africa; Tanzania; Togo; Tunisia; Uganda; Zambia; Zimbabwe |
|
7 |
Intellectual property and public health: Case law database |
01/06/2020 |
Albania; Antigua and Barbuda; Argentina; Armenia; Bahrain, Kingdom of; Barbados; Belize; Bolivia, Plurinational State of; Botswana; Brazil; Brunei Darussalam; Cabo Verde; Cameroon; Chile; China; Colombia; Congo; Costa Rica; Côte d'Ivoire; Cuba; Dominica; Dominican Republic; Ecuador; Egypt; El Salvador; Eswatini; Fiji; Gabon; Georgia; Ghana; Grenada; Guatemala; Guyana; Honduras; Hong Kong, China; India; Indonesia; Israel; Jamaica; Jordan; Kazakhstan; Kenya; Korea, Republic of; Kuwait, the State of; Kyrgyz Republic; Macao, China; Malaysia; Maldives; Mauritius; Mexico; Moldova, Republic of; Mongolia; Montenegro; Morocco; Namibia; Nicaragua; Nigeria; North Macedonia; Oman; Pakistan; Panama; Papua New Guinea; Paraguay; Peru; Philippines; Qatar; Russian Federation; Saint Kitts and Nevis; Saint Lucia; Saint Vincent and the Grenadines; Samoa; Saudi Arabia, Kingdom of; Seychelles; Singapore; South Africa; Sri Lanka; Suriname; Chinese Taipei; Tajikistan; Thailand; Tonga; Trinidad and Tobago; Tunisia; Türkiye; Ukraine; United Arab Emirates; Uruguay; Vanuatu; Venezuela, Bolivarian Republic of; Viet Nam; Zimbabwe |
|
8 |
Partnership for capacity building and technical assistance on IP rights and sustainable development |
01/07/2021 |
Albania; Antigua and Barbuda; Argentina; Armenia; Bahrain, Kingdom of; Barbados; Belize; Bolivia, Plurinational State of; Botswana; Brazil; Brunei Darussalam; Cabo Verde; Cameroon; Chile; China; Colombia; Congo; Costa Rica; Côte d'Ivoire; Cuba; Dominica; Dominican Republic; Ecuador; Egypt; El Salvador; Eswatini; Fiji; Gabon; Georgia; Ghana; Grenada; Guatemala; Guyana; Honduras; Hong Kong, China; India; Indonesia; Israel; Jamaica; Jordan; Kazakhstan; Kenya; Korea, Republic of; Kuwait, the State of; Kyrgyz Republic; Macao, China; Malaysia; Maldives; Mauritius; Mexico; Moldova, Republic of; Mongolia; Montenegro; Morocco; Namibia; Nicaragua; Nigeria; North Macedonia; Oman; Pakistan; Panama; Papua New Guinea; Paraguay; Peru; Philippines; Qatar; Russian Federation; Saint Kitts and Nevis; Saint Lucia; Saint Vincent and the Grenadines; Samoa; Saudi Arabia, Kingdom of; Seychelles; Singapore; South Africa; Sri Lanka; Suriname; Chinese Taipei; Tajikistan; Thailand; Tonga; Trinidad and Tobago; Tunisia; Türkiye; Ukraine; United Arab Emirates; Uruguay; Vanuatu; Venezuela, Bolivarian Republic of; Viet Nam; Zimbabwe |
|